OR8G2P

Across TCGA pan-cancer cohorts, OR8G2P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR8G2P data layer compared with 11 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR8G2P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR8G2P expression acts as an unfavorable survival marker.

STAD, UCEC, and SKCM are the cancer types where OR8G2P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	IV	0.111	0.433	.002	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	DFS	Median	III,IV	0.135	0.654	.010	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR8G2P–STAD (OS)

Open the STAD breakdown →